EVGN
Price
$1.42
Change
+$0.04 (+2.90%)
Updated
Feb 21 closing price
Capitalization
9.56M
12 days until earnings call
KZR
Price
$6.05
Change
-$0.35 (-5.47%)
Updated
Feb 21 closing price
Capitalization
44.14M
19 days until earnings call
Ad is loading...

EVGN vs KZR

Header iconEVGN vs KZR Comparison
Open Charts EVGN vs KZRBanner chart's image
Evogene
Price$1.42
Change+$0.04 (+2.90%)
Volume$17.47K
Capitalization9.56M
Kezar Life Sciences
Price$6.05
Change-$0.35 (-5.47%)
Volume$9.11K
Capitalization44.14M
EVGN vs KZR Comparison Chart
Loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVGN vs. KZR commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a Hold and KZR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (EVGN: $1.42 vs. KZR: $6.05)
Brand notoriety: EVGN and KZR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVGN: 40% vs. KZR: 25%
Market capitalization -- EVGN: $9.56M vs. KZR: $44.14M
EVGN [@Biotechnology] is valued at $9.56M. KZR’s [@Biotechnology] market capitalization is $44.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVGN’s FA Score shows that 0 FA rating(s) are green whileKZR’s FA Score has 1 green FA rating(s).

  • EVGN’s FA Score: 0 green, 5 red.
  • KZR’s FA Score: 1 green, 4 red.
According to our system of comparison, KZR is a better buy in the long-term than EVGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVGN’s TA Score shows that 3 TA indicator(s) are bullish while KZR’s TA Score has 6 bullish TA indicator(s).

  • EVGN’s TA Score: 3 bullish, 6 bearish.
  • KZR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, KZR is a better buy in the short-term than EVGN.

Price Growth

EVGN (@Biotechnology) experienced а -8.40% price change this week, while KZR (@Biotechnology) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

EVGN is expected to report earnings on May 22, 2025.

KZR is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KZR($44.1M) has a higher market cap than EVGN($9.56M). KZR YTD gains are higher at: -9.970 vs. EVGN (-24.225). EVGN has higher annual earnings (EBITDA): -20.4M vs. KZR (-93.11M). KZR has more cash in the bank: 148M vs. EVGN (20M). EVGN has less debt than KZR: EVGN (11M) vs KZR (16.9M). EVGN has higher revenues than KZR: EVGN (7.48M) vs KZR (0).
EVGNKZREVGN / KZR
Capitalization9.56M44.1M22%
EBITDA-20.4M-93.11M22%
Gain YTD-24.225-9.970243%
P/E Ratio0.30N/A-
Revenue7.48M0-
Total Cash20M148M14%
Total Debt11M16.9M65%
FUNDAMENTALS RATINGS
EVGN vs KZR: Fundamental Ratings
EVGN
KZR
OUTLOOK RATING
1..100
319
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9461
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZR's Valuation (13) in the Biotechnology industry is in the same range as EVGN (41). This means that KZR’s stock grew similarly to EVGN’s over the last 12 months.

KZR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EVGN (100). This means that KZR’s stock grew similarly to EVGN’s over the last 12 months.

KZR's SMR Rating (97) in the Biotechnology industry is in the same range as EVGN (100). This means that KZR’s stock grew similarly to EVGN’s over the last 12 months.

KZR's Price Growth Rating (61) in the Biotechnology industry is somewhat better than the same rating for EVGN (94). This means that KZR’s stock grew somewhat faster than EVGN’s over the last 12 months.

EVGN's P/E Growth Rating (88) in the Biotechnology industry is in the same range as KZR (100). This means that EVGN’s stock grew similarly to KZR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVGNKZR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VICR63.6711.81
+22.77%
Vicor Corp
STGW6.300.15
+2.44%
Stagwell
GFI18.70-0.50
-2.60%
Gold Fields Ltd
OPTN5.77-0.23
-3.83%
OptiNose Inc
RLMD0.29-0.02
-6.05%
Relmada Therapeutics

EVGN and

Correlation & Price change

A.I.dvisor tells us that EVGN and AXON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVGN and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
+2.46%
AXON - EVGN
30%
Poorly correlated
-5.28%
FATE - EVGN
29%
Poorly correlated
-8.09%
ARRY - EVGN
28%
Poorly correlated
-4.49%
KZR - EVGN
28%
Poorly correlated
-5.47%
RARE - EVGN
27%
Poorly correlated
-4.25%
More

KZR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with AMRN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
-5.47%
AMRN - KZR
56%
Loosely correlated
-0.82%
CNTB - KZR
47%
Loosely correlated
+1.17%
SAGE - KZR
36%
Loosely correlated
+2.24%
RAPT - KZR
34%
Loosely correlated
-0.79%
CTMX - KZR
34%
Loosely correlated
-4.42%
More